Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers
Standard
Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers. / Tober-Lau, Pinkus; Schwarz, Tatjana; Vanshylla, Kanika; Hillus, David; Gruell, Henning; Suttorp, Norbert; Landgraf, Irmgard; Kappert, Kai; Seybold, Joachim; Drosten, Christian; Klein, Florian; Kurth, Florian; Sander, Leif Erik; Corman, Victor Max; EICOV/COVIM Study Group.
in: LANCET RESP MED, Jahrgang 9, Nr. 11, 11.2021, S. e104-e105.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers
AU - Tober-Lau, Pinkus
AU - Schwarz, Tatjana
AU - Vanshylla, Kanika
AU - Hillus, David
AU - Gruell, Henning
AU - Suttorp, Norbert
AU - Landgraf, Irmgard
AU - Kappert, Kai
AU - Seybold, Joachim
AU - Drosten, Christian
AU - Klein, Florian
AU - Kurth, Florian
AU - Sander, Leif Erik
AU - Corman, Victor Max
AU - EICOV/COVIM Study Group
PY - 2021/11
Y1 - 2021/11
KW - Aged
KW - BNT162 Vaccine/immunology
KW - COVID-19/prevention & control
KW - Health Personnel
KW - Humans
KW - Immunogenicity, Vaccine
KW - Vaccination
U2 - 10.1016/S2213-2600(21)00456-2
DO - 10.1016/S2213-2600(21)00456-2
M3 - Other (editorial matter etc.)
C2 - 34687656
VL - 9
SP - e104-e105
JO - LANCET RESP MED
JF - LANCET RESP MED
SN - 2213-2600
IS - 11
ER -